NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised people

A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have declined, while additional dose is given to immunocompromised and immunosuppressed individuals when primary schedule of vaccination does not provide adequate protection from the infection and disease, they explained.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/331vU9D
via IFTTT